Hymenoptera Venom Diagnostic
NDC Package 52709-1401-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Hymenoptera Venom Diagnostic is a . Marketed by Alk-abello A S, this product is identified by NDC 52709-1401 and is authorized under FDA application BLA123456.

Identification & Billing

NDC Package Code
52709-1401-1
Package Description
1 KIT in 1 PACKAGE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE
Product Code
52709-1401
11-Digit Billing Format
52709140101
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.

Clinical Specifications

Proprietary Name
Hymenoptera Venom Diagnostic
Dosage Form
-

Regulatory & Marketing

Labeler Name
Alk-abello A S
FDA Application #
BLA123456
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
11-20-1992
End Marketing Date
06-06-2016
Listing Expiration
06-06-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage
  • 52709 - Alk-abello A S
    • 52709-1401 - Hymenoptera Venom Diagnostic
      • 52709-1401-1 - 1 KIT in 1 PACKAGE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52709-1401-1 identifies a specific commercial package of 1 kit in 1 package * 1 injection, powder, lyophilized, for solution in 1 vial, multi-dose * 1 injection, powder, lyophilized, for solution in 1 vial, multi-dose * 1 injection, powder, lyophilized, for solution in 1 vial, multi-dose * 1 injection, powder, lyophilized, for solution in 1 vial, multi-dose * 1 injection, powder, lyophilized, for solution in 1 vial, multi-dose of Hymenoptera Venom Diagnostic, labeled by Alk-abello A S. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Alk-abello A S on November 20, 1992. The current certification is valid through June 06, 2016.

How is this Alk-abello A S product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52709140101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
52709-1401-1
11-Digit CMS (5-4-2)
52709-1401-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.